COPPELL, Texas--(BUSINESS WIRE)--Dec. 8, 2016--
Mannatech®,
Incorporated (NASDAQ: MTEX) (“Mannatech”), a global health and
wellness company committed to transforming lives to make a better world,
today announced the appointment of Kevin Robbins to its Board of
Directors.
“Kevin brings to the Board 22 years of invaluable Mannatech field
experience and perspective as well as extensive service as a leader of
our independent sales Associates,” said J. Stanley Fredrick, Chairman of
the Board of Mannatech. “We are proud to continue the legacy of having
field representation on the Board. Kevin’s unique knowledge about how we
work with our Associates and customers helps make him a valued asset and
member of Mannatech’s Board of Directors.”
Robbins, son of Mannatech co-founder Ray Robbins, began his part time
Mannatech career in 1994. By 1996, Kevin was able to dedicate his career
to Mannatech full time. In 2003, he was awarded as the global recipient
of the Ray Robbins Giving Spirit Award. Then, in 2012, Kevin was
recognized as one of the Top Global Business Builders of the Year.
Robbins has been a leader for Mannatech since 2000, when he was elected
to represent Mannatech’s North America field as part of the North
American Advisory Council. He originally served five years on the
advisory council, and was later re-elected for another three-year term.
As part of the advisory council, Kevin served as Chairman for five years
where he worked closely with the company to develop new compensation
plans, new incentive trips and training programs with respect to
independent sales Associates in North America.
Robbins earned a Bachelor of Business Administration in Marketing at The
University of Texas at Arlington.
About Mannatech
Mannatech offers a profound wellness experience through a financially
rewarding opportunity that makes a difference in the lives of people
across the world. Through its innovative Glyconutrition products,
Mannatech changes lives, providing an unprecedented level of natural
wellness*, freedom and purpose. With more than 20 years of experience
and operations in 25 countries, Mannatech is committed to changing
lives. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain associates and
members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
*These statements have not been evaluated by the Food and Drug
Administration. These products are not intended to diagnose, treat, cure
or prevent any disease.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161208006227/en/
Source: Mannatech, Incorporated
Mannatech, Incorporated
Kalyn Dabbs, 972-471-7245
pr@mannatech.com